Is GPT Healthcare IPO Worth applying? | GPT Healthcare IPO Review
Watch GPT Healthcare IPO Review to get the top 3 explanations that will provide you with explicit reasons whether you should apply for the GPT Healthcare IPO or not!
This multispecialist hospital brand revenue has increased by 47% in FY23 from FY21, furthermore, GPT Healthcare has been paying its debts to creditors timely, and additionally, its net profits have also increased.
About GPT Healthcare:
GPT Healthcare Limited is the Healthcare arm of GPT Group, which owns and operates Multispecialty neighborhood tertiary care hospitals in Eastern India, under the ILS Hospitals brand. The company operates a chain of mid-sized full-service multispecialty hospitals in Eastern India under the brand and provides integrated healthcare services, with a focus on secondary and tertiary care.
The company offers a comprehensive range of healthcare services across over 35 specialties and super specialties, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynecology and obstetrics, critical care, gastroenterology, orthopedics and joint replacements, interventional cardiology, neurology, neurosurgery, pediatrics, and neonatology.
Research report of GPT healthcare
Join Us For all the latest updates about startups, preipo and unicorns.
Keep yourself updated with the market situation.
Join us on Facebook
Contact us at +91 7065560002 via Whatsapp/Normal call
Or Mail us at help@planify.in
⬇️ Download the app for easy access. Links are given below:
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated research reports, delivered straight to your WhatsApp.